The current ratio below 1 (approximately 0.72) indicates liquidity constraints, reflecting that current liabilities exceed current assets, which could pressure short-term financial flexibility.

The quick ratio near 0.51 suggests the company may struggle to cover short-term obligations without relying on inventory liquidation, signaling potential liquidity risk especially during periods of market stress.

Liquidity ratios have been relatively stable over recent quarters with slight fluctuations but show no significant improvement, implying consistent but tight working capital management.

There is moderate risk of a short-term cash crunch if unexpected obligations arise, given the low current and quick ratios, though Procter & Gamble’s size and cash flow generation mitigate this concern to some extent.

A debt-to-equity ratio of approximately 0.69 indicates moderate leverage, typical for a large stable consumer goods firm, balancing debt use for growth with conservative capital structure management.

Debt to assets near 29% shows a moderately leveraged balance sheet, not excessively risky but notable enough to demand consistent earnings to service debt.

Despite a negative interest coverage ratio reported (likely due to timing or accounting factors), Procter & Gamble’s large free cash flows and credit profile suggest it can sustain and service its debt comfortably under normal operating conditions.

Long term, the company’s established market position and cash flow generation bode well for financial health, but persistent cost pressures and economic volatility could affect debt metrics if unchecked.

PG’s beta near 0.42 signals lower volatility than the market average, consistent with its defensive sector status, offering some downside protection.

Compared to peers, PG is less volatile, reflecting its stable consumer goods business and predictable revenue streams.

Exposure to interest rate increases and recession risks exists due to its debt load and consumer spending sensitivity, but the essential nature of its products mitigates this somewhat.

There is moderate upside from stable dividend growth, modest organic sales growth, and productivity improvements supporting EPS expansion. Analysts average a 12-month price target around $168, which is about 5% above current prices.

Risks include margin compression from tariffs and costs, slowing consumer demand, restructuring charges, and possible negative consumer sentiment, which could pressure earnings and share price.

The moderate risk level with steady dividends and consistent cash flows provides a balanced risk-reward profile, though returns may be tempered by cost and demand headwinds.

Investors seeking income and stable exposure to consumer staples may consider moderate position sizing; risk-tolerant investors should weigh awareness of macro and operational risks when allocating.